|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2004)) |
IUPAC Name ![]() |
| (5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 4972 | iloprost |
Synonyms ![]() |
| Ventavis® |
Database Links ![]() |
|
| CAS Registry No. | 78919-13-8 |
| ChEBI | CHEBI:63916 |
| ChEMBL Ligand | CHEMBL236025 |
| DrugBank Ligand | DB01088 |
| PubChem CID | 6435378 |
| Search Google for chemical match using the InChIKey | HIFJCPQKFCZDDL-SGSAMSKHSA-N |
| Search Google for chemicals with the same backbone | HIFJCPQKFCZDDL |
| Search PubMed clinical trials | iloprost |
| Search PubMed titles | iloprost |
| Search PubMed titles/abstracts | iloprost |
| Wikipedia | Iloprost |
| Comments |
| Iloprost is a synthetic analogue of PGI2. |